USE OF MAD2L2 AS A STRATIFICATION MARKER IN THE TREATMENT OF BREAST TUMOURS WITH NOVEL PAN-CDK INHIBITORS
The invention relates to the use of MAD2L2 as stratification marker in the treatment of breast tumours with novel pan-CDK inhibitors of the formula (I).
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | The invention relates to the use of MAD2L2 as stratification marker in the treatment of breast tumours with novel pan-CDK inhibitors of the formula (I). |
|---|